The collective efforts of many AVMA volunteers and AVMA staff really paid dividends when the U.S. Food and Drug Administration yesterday announced significant changes to veterinary feed directive (VFD) regulations that will require veterinary oversight of antimicrobial use in livestock.
Members of our Steering Committee for FDA Policy on Veterinary Oversight of Antimicrobials, as well as AVMA staff, were instrumental in shaping this favorable outcome for the veterinary profession and those veterinarians who work so closely with livestock producers.
The AVMA has long been a proponent of judicious drug use by veterinarians, having historically worked with the FDA and other stakeholders to help develop principles and processes that foster the appropriate and judicious use of medically important antimicrobials. For years, the Steering Committee for FDA Policy on Veterinary Oversight of Antimicrobials has been engaged with the FDA Center for Veterinary Medicine on discussions related to veterinary oversight. We are pleased to have had the opportunity to engage in dialogue with the FDA on this topic.
Our membership has a strong, vested interest in ensuring that the VFD regulations are an efficient and appropriate mechanism for veterinary use of antimicrobials in livestock and poultry. The FDA’s acknowledgement of the necessity to update and streamline the existing requirements related to the distribution and use of VFD drugs in order to facilitate the transition of certain new animal drug products from over-the-counter status to a status that requires veterinary oversight is commendable.
The FDA’s Final Guidance 213 establishes a three-year timeframe for phasing out growth-promotion uses of antibiotics important in human medicine and the phasing in of veterinary oversight. For more on the issue, read the AVMA’s press release.